Amy Feng

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.

M. Lebwohl, Z. Draelos, M. Gooderham, 2022, JAMA.

Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial

M. Lebwohl, M. Gooderham, K. Papp, 2022, American Journal of Clinical Dermatology.

Roflumilast Cream 0.3% Improved the Severity and Impact of Itch in Patients With Chronic Plaque Psoriasis in the Phase 3 DERMIS-1 and DERMIS-2 Studies

M. Lebwohl, M. Gooderham, K. Papp, 2021, SKIN The Journal of Cutaneous Medicine.

Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials

M. Lebwohl, Z. Draelos, M. Gooderham, 2021, SKIN The Journal of Cutaneous Medicine.